Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.

Saved in:
Bibliographic Details
Title: Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.
Authors: Desrochers J; Medical & Translational Sciences, Novo Nordisk A/S, Søborg 2860, Denmark., Backeljauw P; Division of Diabetes and Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA., Højby M; Medical & Translational Sciences, Novo Nordisk A/S, Søborg 2860, Denmark., Juul Kildemoes R; Medical & Translational Sciences, Novo Nordisk A/S, Søborg 2860, Denmark., Linglart A; Université Paris-Saclay, AP-HP, INSERM, Service d'Endocrinologie et diabète de l'enfant, Hôpital Bicêtre Paris Saclay, F-94270 Le Kremlin-Bicêtre, France., Mori J; Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital, Osaka 534-0021, Japan., Leisegang RF; Medical & Translational Sciences, Novo Nordisk A/S, Søborg 2860, Denmark.
Source: Journal of the Endocrine Society [J Endocr Soc] 2026 Jun 04; Vol. 10 (7), pp. bvag124. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Endocrine Society Country of Publication: United States NLM ID: 101697997 Publication Model: eCollection Cited Medium: Internet ISSN: 2472-1972 (Electronic) Linking ISSN: 24721972 NLM ISO Abbreviation: J Endocr Soc Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2472-1972
DOI:10.1210/jendso/bvag124